Clinical trial
Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus
NCT00325325 · Hospital Universitario Ramon y Cajal, Other · Unknown status
Key facts
| NCT number | NCT00325325 |
|---|---|
| Title | Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus |
| Official title | A Pilot Study to Investigate Pharmacokinetic Characteristics of Everolimus in Patients Treated With Tacrolimus-Based Immunosuppression in De Novo Kidney Transplantation |
| Lead sponsor | Hospital Universitario Ramon y Cajal, Other |
| Collaborators | Novartis Industry Astellas Pharma Inc |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Diseases |
| Intervention type | Drug |
| Interventions | everolimus and tacrolimus |
| Enrollment | 40 |
| Start date | Jan 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | May 12, 2006 |
| Last update posted | Oct 26, 2006 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: